- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Globus Medical (GMED)Globus Medical stock price live, this page displays NYSE GMED stock exchange data. View the GMED premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Globus Medical real time stock price chart below.
What Is the Globus Medical Stock Price Today?
The Globus Medical stock price today is 82.92.
What Is the Stock Symbol for Globus Medical?
The stock symbol for Globus Medical is "GMED."
What Stock Exchange Does Globus Medical Trade On?
Globus Medical is listed and trades on the NYSE stock exchange.
Is Globus Medical a Good Stock to Buy?
Determining whether Globus Medical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GMED quote. (ISIN: US3795772082)
What Is the Globus Medical Stock Price Today?
The Globus Medical stock price today is 82.92.
What Is the Stock Symbol for Globus Medical?
The stock symbol for Globus Medical is "GMED."
What Stock Exchange Does Globus Medical Trade On?
Globus Medical is listed and trades on the NYSE stock exchange.
Is Globus Medical a Good Stock to Buy?
Determining whether Globus Medical—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GMED quote. (ISIN: US3795772082)
82.92
-0.40(-0.48%)
Closed
After Hours
83.79+0.87(+1.05%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
82.57
83.65
52 wk Range
46.75
87.22
GMED Scorecard
Full Analysis
Management has been aggressively buying back shares
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
82.5783.65
52 wk Range
46.7587.22
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
UnlockEV/EBITDA
UnlockBeta
GMED Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Neutral
Price Target
92.38
Upside
+11.41%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Net income is expected to grow this year
Globus Medical Company Profile
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Globus Medical SWOT Analysis
Merger Momentum | Globus Medical's merger with NuVasive creates a mid-teens market share player in spine industry, driving significant revenue growth and synergies |
Robotic Surgery Leade | Explore GMED's strong position in robotic surgery, a key growth driver with rising sales and implant pull-through expected to boost future performance |
Financial Strength | Learn about GMED's impressive Q3 2024 results, with revenues reaching $625.7 million and adjusted EPS of $0.83, surpassing market expectations |
Analyst Outlook | Average price target range of $78-$100, with analysts maintaining bullish ratings despite regulatory challenges and integration complexities |
GMED Full Pro Research
Institutional-Grade Stock Analysis
Understand how GMED earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
Globus Medical Earnings Call Summary for Q3/2024
- Q2 revenue up 116% to $630M; non-GAAP EPS rose 20% to $0.75, boosted by NuVasive acquisition
- Full-year net sales projected at $2.47B-$2.49B; non-GAAP EPS expected between $2.80-$2.90
- Launched 4 new products; record launches expected in coming months; focus on robotics and market expansion
- Aims for $170M in cost synergies and mid-70s gross profit profile long-term; slight Q3 EBITDA margin dip expected
- Plans to settle convertible notes due in March in cash; rental program for enabling technology driven by customer preference
Last Updated: 2024-08-07, 11:04 a/m
Read Full TranscriptCompare GMED to Peers and Sector
Metrics to compare | GMED | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGMEDPeersSector | |
|---|---|---|---|---|
P/E Ratio | 123.4x | −15.1x | −0.6x | |
PEG Ratio | −2.28 | −0.10 | 0.00 | |
Price/Book | 2.8x | 3.1x | 2.6x | |
Price / LTM Sales | 4.6x | 3.1x | 3.2x | |
Upside (Analyst Target) | 11.0% | 57.6% | 46.2% | |
Fair Value Upside | Unlock | −3.2% | 7.0% | Unlock |
Analysts' Recommendations
10 Buy
4 Hold
1 Sell
Ratings:
13 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 92.38
(+11.41% Upside)
People Also Watch
FAQ
What Is the Globus Medical (GMED) Stock Price Today?
The Globus Medical stock price today is 82.92
What Stock Exchange Does Globus Medical Trade On?
Globus Medical is listed and trades on the NYSE stock exchange.
What Is the Stock Symbol for Globus Medical?
The stock symbol for Globus Medical is "GMED."
What Is the Globus Medical Market Cap?
As of today, Globus Medical market cap is 11.31B.
What is Globus Medical Earnings Per Share?
The Globus Medical EPS is 0.673.
What Is the Next Globus Medical Earnings Date?
Globus Medical will release its next earnings report on Feb 20, 2025.
From a Technical Analysis Perspective, Is GMED a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.